Equitable saw no growth in patent filings and highest growth of 0.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of Equitable’s patent filings and grants. Buy the databook here.
Equitable has been focused on protecting inventions in China(CN) with one publication in Q2 2024
The China(CN) Patent Office dominates the patent grants with nearly 100% of grants. The China(CN) patent Office are among the top ten patent offices where Equitable is filings its patents. Among the top granted patent authorities, Equitable has 100% of its grants in China(CN).
International Business Machines and Microsoft could be the strongest competitors for Equitable
Paints and inks related patents lead Equitable portfolio followed by wounds
Equitable has highest number of patents in paints and inks followed by wounds.
For comprehensive analysis of Equitable's filings and grants, buy the databook here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.